Skip to content

August 26, 2019

Diplomat considers sale, merger

Diplomat considers sale, merger

Diplomat Pharmacy is considering a sale or merger after seeing revenue declines in its PBM and specialty segments in the second quarter ended June 30. The company’s board ordered the exploration of “strategic alternatives” after Diplomat’s quarterly revenue dropped 9% from the year-ago period to $1.

CVS addresses sunscreen concerns

CVS addresses sunscreen concerns

CVS Health announced it will be taking another step forward in its efforts to remove chemicals of concern to consumers by eliminating oxybenzone and octinoxate from nearly 60 CVS Health brand sunscreen products under SPF 50 by the end of 2020.

Platforms poised to elevate consumer engagement

Platforms poised to elevate consumer engagement

The legacy business model in consumer and retail is the pipe through which value is generated upstream and delivered to consumers downstream. As everyone is aware, a powerful alternative has emerged. Today “platform” enterprises such as Alibaba, Amazon, Tencent and Uber are dominant business titans.